Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-Resistant Prostatic Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03522064
What this trial is testing

Bipolar Androgen Therapy + Carboplatin in mCRPC

Who this might be right for
Castration-resistant Prostate CancerHomologous Recombination Deficiency
St Vincent's Hospital, Sydney 30
Not applicableLooking for participantsNCT05647564
What this trial is testing

PET/CT Characterization of Treatment Resistance

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 25
Testing effectiveness (Phase 2)Ended earlyNCT01450683
What this trial is testing

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Stanford University 4
Early research (Phase 1)Ended earlyNCT03300505
What this trial is testing

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT06457919
What this trial is testing

Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT04424654
What this trial is testing

Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy

Who this might be right for
Prostate Cancer
Hospital Sirio-Libanes 20
Testing effectiveness (Phase 2)Looking for participantsNCT07226713
What this trial is testing

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

Who this might be right for
Prostate Cancer
Medical College of Wisconsin 32
Testing effectiveness (Phase 2)Looking for participantsNCT06378866
What this trial is testing

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Who this might be right for
Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more
Mayo Clinic 532
Testing effectiveness (Phase 2)Study completedNCT01685983
What this trial is testing

Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Study completedNCT04558866
What this trial is testing

Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)

Who this might be right for
Prostate Cancer
Latin American Cooperative Oncology Group 51
Large-scale testing (Phase 3)Study completedNCT03016312
What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Hoffmann-La Roche 759
Not applicableEnded earlyNCT03440879
What this trial is testing

Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose

Who this might be right for
Prostate CancerResistance ExerciseAndrogen Deprivation Therapy
Norwegian School of Sport Sciences 23
Early research (Phase 1)Active Not RecruitingNCT06305598
What this trial is testing

Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Roswell Park Cancer Institute 3
Not applicableLooking for participantsNCT06449664
What this trial is testing

Training for Men Undergoing Androgen Deprivation Therapy.

Who this might be right for
Prostate Cancer
The Swedish School of Sport and Health Sciences 60
Testing effectiveness (Phase 2)Study completedNCT02987829
What this trial is testing

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Who this might be right for
Metastatic Castrate-resistant Prostate CancerAdenocarcinoma, Prostate
Tracon Pharmaceuticals Inc. 72
Large-scale testing (Phase 3)Looking for participantsNCT07311694
What this trial is testing

A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 370
Testing effectiveness (Phase 2)Study completedNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Not applicableStudy completedNCT01909440
What this trial is testing

Resistance Training and Protein Supplementation for Prostate Cancer Survivors

Who this might be right for
Prostate Cancer
University of Southern California 43
Testing effectiveness (Phase 2)WithdrawnNCT02065323
What this trial is testing

Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

Who this might be right for
Prostate Cancer
Oscar Goodman, Jr.
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Next Page